9996 — Peijia Medical Income Statement
0.000.00%
Last trade - 00:00- HK$3.38bn
- HK$2.91bn
- CNY615.48m
Annual income statement for Peijia Medical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 38.7 | 137 | 251 | 441 | 615 |
| Cost of Revenue | |||||
| Gross Profit | 25.2 | 95.7 | 176 | 325 | 434 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 442 | 735 | 693 | 872 | 855 |
| Operating Profit | -404 | -599 | -443 | -431 | -239 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -2,069 | -574 | -398 | -392 | -222 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2,069 | -574 | -408 | -393 | -228 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -2,069 | -574 | -408 | -393 | -227 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2,069 | -574 | -408 | -393 | -227 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -4.37 | -0.868 | -0.605 | -0.578 | -0.338 |